The mutational landscape of melanoma in adolescents and young adults

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Melanoma is the most common cause of cancer mortality in 20-34 year olds and many traditional treatments, chemotherapy and radiotherapy cause tremendous long-term damage to growing bodies. Fortunately new drugs that target the genetic mutations are proving effective. Unfortunately, the genomic mutation specific to young melanoma patients are unknown. This study aims to characterising the genomic mutations of young melanoma patients, leading to the discovery of innovative treatment options.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2019

Funding Scheme: Early Career Fellowships

Funding Amount: $314,644.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cancer Genetics

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cancer biology | genetic mapping | melanoma | oncogenes | young adults